BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16574217)

  • 41. Biodegradable heparin-loaded microspheres: carrier molecular composition and microsphere structure.
    Luo X; Qiu D; He B; Wang L; Luo J
    Macromol Biosci; 2006 May; 6(5):373-81. PubMed ID: 16685689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Robust polymer microfluidic device fabrication via contact liquid photolithographic polymerization (CLiPP).
    Hutchison JB; Haraldsson KT; Good BT; Sebra RP; Luo N; Anseth KS; Bowman CN
    Lab Chip; 2004 Dec; 4(6):658-62. PubMed ID: 15570381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A mixture model for water uptake, degradation, erosion and drug release from polydisperse polymeric networks.
    Soares JS; Zunino P
    Biomaterials; 2010 Apr; 31(11):3032-42. PubMed ID: 20129660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fabrication of polymer microstructures for MEMS: sacrificial layer micromolding and patterned substrate micromolding.
    Ferrell N; Woodard J; Hansford D
    Biomed Microdevices; 2007 Dec; 9(6):815-21. PubMed ID: 17564840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineered polymers and polymeric systems in controlled drug delivery and targeting. Preface.
    Avgoustakis K
    Eur J Pharm Biopharm; 2009 Mar; 71(3):407-8. PubMed ID: 19150405
    [No Abstract]   [Full Text] [Related]  

  • 49. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
    Rothenfluh DA; Hubbell JA
    Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Producing monodisperse drug-loaded polymer microspheres via cross-flow membrane emulsification: the effects of polymers and surfactants.
    Meyer RF; Rogers WB; McClendon MT; Crocker JC
    Langmuir; 2010 Sep; 26(18):14479-87. PubMed ID: 20731340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3D lithographically fabricated nanoliter containers for drug delivery.
    Randall CL; Leong TG; Bassik N; Gracias DH
    Adv Drug Deliv Rev; 2007 Dec; 59(15):1547-61. PubMed ID: 17919768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Porous nanoparticles in drug delivery systems.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-definition polymeric membranes: construction of 3D lithographed channel arrays through control of natural building blocks dynamics.
    Speranza V; Trotta F; Drioli E; Gugliuzza A
    ACS Appl Mater Interfaces; 2010 Feb; 2(2):459-66. PubMed ID: 20356192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres.
    Pfeifer BA; Burdick JA; Langer R
    Biomaterials; 2005 Jan; 26(2):117-24. PubMed ID: 15207458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel functional hyperbranched polyether polyols as prospective drug delivery systems.
    Tziveleka LA; Kontoyianni C; Sideratou Z; Tsiourvas D; Paleos CM
    Macromol Biosci; 2006 Feb; 6(2):161-9. PubMed ID: 16456875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of TRI-726 as a drug delivery matrix.
    Mondal P; Alur HH; Johnston TP
    Drug Dev Ind Pharm; 2011 Aug; 37(8):995-1001. PubMed ID: 21417600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thiomers: forms, functions and applications to nanomedicine.
    Albrecht K; Bernkop-Schnürch A
    Nanomedicine (Lond); 2007 Feb; 2(1):41-50. PubMed ID: 17716189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biocompatibility and resorption of intravenously administered polymer microparticles in tissues of internal organs of laboratory animals.
    Shishatskaya E; Goreva A; Kalacheva G; Volova T
    J Biomater Sci Polym Ed; 2011; 22(16):2185-203. PubMed ID: 21067658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug releasing polymer thin films: new era of surface-mediated drug delivery.
    Zelikin AN
    ACS Nano; 2010 May; 4(5):2494-509. PubMed ID: 20423067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.